During routine urinalysis, 1-2 hyaline casts per high-power field are found with otherwise normal results. What is the most appropriate interpretation?

Prepare effectively for the Physician Assistant Clinical Knowledge Rating and Assessment Tool (PACKRAT) 1 Exam with comprehensive resources, flashcards, and detailed explanations. Ace your test with ease!

Multiple Choice

During routine urinalysis, 1-2 hyaline casts per high-power field are found with otherwise normal results. What is the most appropriate interpretation?

Explanation:
Hyaline casts are the most common type of urinary cast and are made primarily of Tamm-Horsfall protein. They’re non-specific and can appear with normal aging, concentrated urine, mild dehydration, exercise, or fever. Seeing a small number—about 1 to 2 per high-power field—while the rest of the urinalysis is normal is considered a benign, physiologic finding rather than evidence of renal disease. Because there’s no other abnormality in the urinalysis and the patient is asymptomatic, the appropriate interpretation is to do nothing further at this time (no culture, no nephrology referral, and no imaging). If future tests show additional abnormal casts, proteinuria, hematuria, or other signs of kidney dysfunction, that would prompt further evaluation.

Hyaline casts are the most common type of urinary cast and are made primarily of Tamm-Horsfall protein. They’re non-specific and can appear with normal aging, concentrated urine, mild dehydration, exercise, or fever. Seeing a small number—about 1 to 2 per high-power field—while the rest of the urinalysis is normal is considered a benign, physiologic finding rather than evidence of renal disease.

Because there’s no other abnormality in the urinalysis and the patient is asymptomatic, the appropriate interpretation is to do nothing further at this time (no culture, no nephrology referral, and no imaging). If future tests show additional abnormal casts, proteinuria, hematuria, or other signs of kidney dysfunction, that would prompt further evaluation.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy